Project Grant R01HD112559

Award Date 6/13/24
Completion Date 4/30/29
Dollars Obligated $1.9M
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Kansas City, KS 66160, USA
Similar Awards
This National Science Foundation (NSF) Biological Sciences project grant, awarded to Worcester Polytechnic Institute (WPI), aims to better understand the role of trophoblast cells and extracellular vesicles (exosomes) in placental function and development. The $502,999 award, effective June 15, 2024 through May 31, 2027, will focus on two key objectives: 1) characterizing how oxygen levels and biochemical factors influence trophoblast invasion of the extracellular matrix, and 2) examining how...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $130,680 to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) for a project titled "Early Events in Extravillous Trophoblast Cell Differentiation." The research aims to investigate the role of the transcription factor CCAAT/enhancer-binding protein beta (CEBPB)...
This National Science Foundation (NSF) Engineering (CFDA 47.041) Project Grant award to Worcester Polytechnic Institute (WPI) in the amount of $259,570 will develop 3D spheroid models using patient-derived trophoblast cells to investigate placental cell invasion and study preeclampsia, a pregnancy complication with high global maternal and infant mortality rates. The 2-year project will design culture conditions to maintain the spheroid models, engineer an extracellular matrix to mimic the...
This Federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will provide $152,000.00 to North Carolina State University (NC State) for research on the role of the TET2 enzyme in regulating uterine function and fertility. The primary objectives are to determine the in vivo role of TET2 in: 1) regulation of the uterine window of receptivity, and 2) endometrial...
The University of Texas at Austin received a $191,965 Project Grant (R21HD115116) from the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant is funding a 2-year research project to identify and functionally validate key transcription factors that control preeclampsia-specific gene expression programs, and to understand the regulatory mechanisms of these preeclampsia-driving transcription...
The National Institute of Child Health and Human Development (NICHD) awarded a $411,125 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Syracuse University to develop a microfluidic human placenta organoid model. The goal is to generate human trophoblast stem cells (HTSCs) from induced pluripotent stem cells and use them to create a placenta organoid system that can replicate early/mid-gestation placental development. The researchers will study the role of...
This Project Grant award of $3,422,481 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop a comprehensive genomic resource to characterize novel causes of unexplained recurrent pregnancy loss (RPL). The key products and services to be delivered under this 5-year award include: 1) leveraging the hospital's large clinical service for RPL and genetic research program to...
This federal Project Grant award, totaling $456,251.00, was provided by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). The overarching goal of the proposed research is to test the hypothesis that pro-inflammatory mediators produced by maternal adipose tissue (leptin) reduce pro-angiogenic immune cells and factors at the maternal-fetal interface, which can contribute to adverse pregnancy outcomes...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $584,074 to the University of Massachusetts Medical School (UMass Medical) for research on ion channels critical for uterine contraction, reproduction, and adenomyosis. The key objectives are to: Investigate the roles of the L-type calcium channel subunits Cav1.2 and Cav1.3 in calcium signaling,...
This $1,538,070.00 federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support research to investigate the role of mitochondrial nutrient transport in regulating trophoblast differentiation. The project aims to use CRISPR-Cas9 genetic tools to manipulate the expression of the mitochondrial pyruvate carrier (MPC) and glutamine transporter (SLC1A5VAR) in...

PATHWAYS AFFECTING TROPHOBLAST DEVELOPMENT - PROJECT SUMMARY/ABSTRACT TROPHOBLAST CELL DERIVATIVES OF THE EARLY EMBRYO CONTRIBUTE TO RESTRUCTURING THE UTERINE ENVIRONMENT, AN EVENT REQUIRED FOR THE ESTABLISHMENT OF A SUCCESSFUL PREGNANCY. THE HUMAN AND RAT EACH POSSESS A UTERINE- TROPHOBLAST INTERFACE THAT IS CHARACTERIZED BY DEEP INTRAUTERINE INFILTRATION OF TROPHOBLAST CELLS, WHICH CONTRIBUTES TO DYNAMIC CHANGES IN UTERINE IMMUNE CELL, ENDOTHELIAL CELL, SMOOTH MUSCLE CELL, AND STROMAL CELL CONSTITUENTS. THIS IMPORTANT DEVELOPMENTAL PROCESS IS DIRECTED BY SPECIALIZED TROPHOBLAST CELLS POSSESSING INVASIVE PROPERTIES REFERRED EXTRAVILLOUS TROPHOBLAST (EVT) IN THE HUMAN OR BY THE GENERIC TERM INVASIVE TROPHOBLAST CELLS IN OTHER SPECIES, INCLUDING THE RAT. DIFFERENTIATION INTO THESE SPECIALIZED TROPHOBLAST CELL TYPES REQUIRES SUPPRESSION OF PATHWAYS ESSENTIAL FOR MAINTAINING THE TROPHOBLAST CELL STEM STATE AND ACTIVATION OF THE INVASIVE/EVT CELL DIFFERENTIATION PROGRAM. WE HYPOTHESIZE THAT REPRESSION OF THE TROPHOBLAST CELL STEM STATE IS AN EVENT ESSENTIAL FOR THE ESTABLISHMENT OF PREGNANCY. IN THIS PROJECT, WE INVESTIGATE ROLES FOR ACTIVIN-FOLLISTATIN LIKE 3 AND WNT-WNT ANTAGONIST REGULATORY NETWORKS CONTROLLING DEVELOPMENT OF THE INVASIVE/EVT CELL LINEAGE. ROLES FOR THE ACTIVIN-FOLLISTATIN LIKE 3 AND WNT-WNT ANTAGONIST REGULATORY NETWORKS ARE THE FOCUS OF AIMS NOS. 1 AND 2, RESPECTIVELY. IN AIM NO. 3, WE EXAMINE FSTL3 AND THE WNT ANTAGONIST, NOTUM, IN PATIENT-SPECIFIC HUMAN TROPHOBLAST STEM CELLS. EXPERIMENTATION INCLUDES GENOME-WIDE ANALYSES OF THE TRANSCRIPTOME AND THE CHROMATIN LANDSCAPE. EXECUTION OF THIS RESEARCH PROJECT WILL FACILITATE ELUCIDATION OF ELEMENTS OF THE REGULATION OF THE INVASIVE/EVT CELL LINEAGE AND WILL CREATE A PLATFORM FOR UNDERSTANDING THE PATHOGENESIS OF EARLY PREGNANCY LOSS.

Posted 6/12/24, 12:00 AM